Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Irish Stock Exchange  >  Mainstay Medical International PLC    MSTY   IE00BJYS1G50

MAINSTAY MEDICAL INTERNATIONAL PLC (MSTY)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Irish Stock Exchange
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
12.7 12.7 12.7 12.7 12.7 Last
0 0 0 0 0 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
Company
Mainstay Medical International Plc is a medical device company, which is engaged in the development of neurostimulation therapies.The company's focus is on the development of ReActiv8, a medical device designed to treat people with chronic low back pain.The company was founded on February 17, 2014... 
More about the company
Latest news on MAINSTAY MEDICAL INTERNATI
02/17MAINSTAY MEDICAL INTERNATIONAL : Medical firm Mainstay gets 30m funding
AQ
02/16MAINSTAY MEDICAL INTERNATIONAL : raises 30m from new share placing
AQ
2017MAINSTAY MEDICAL INTERNATIONAL : Announces Positive Outcome of Interim Analysis
PU
2017MAINSTAY : Medical’s ReActiv8-B Clinical Trial Passes Mid-point
BU
2017MAINSTAY MEDICAL INTERNATIONAL : to Host Key Opinion Leader Event on the Chronic..
PU
2017DGAP-NEWS : Mainstay Medical International Plc
AQ
2017MAINSTAY MEDICAL INTERNATIONAL : to Present at the 3rd annual Biotech and Money ..
PU
2016MAINSTAY MEDICAL INTERNATIONAL : ReActiv8-A Clinical Trial – Sustained Per..
PU
2016MAINSTAY MEDICAL INTERNATIONAL : 2016 H1 Results Notice
PU
2016WEBCAST – TUESDAY, 21 JUNE 201 : 30 pm EDT
PU
More news
Sector news : Bio Medical Devices
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
02/14BRISTOL MYERS SQUIBB : Nektar to Partner on Cancer Therapy
DJ
02/13Drug copies ready to take next bite out of Roche's cancer sales
RE
More sector news : Bio Medical Devices
Chart MAINSTAY MEDICAL INTERNATI
Duration : Period :
Mainstay Medical Internati Technical Analysis Chart | MSTY | IE00BJYS1G50 | 4-Traders
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 28,0 €
Spread / Average Target 120%
Managers
NameTitle
Jason M. Hannon Chief Executive Officer & Executive Director
Oern Reidar Stuge Independent Non-Executive Chairman
Prashant Rawat Chief Operating Officer
Hugh Kavanagh Chief Financial Officer
Diane Burnside Vice President-Clinical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
MAINSTAY MEDICAL INTERNATIONAL PLC-0.78%105
GILEAD SCIENCES14.21%106 851
VERTEX PHARMACEUTICALS4.94%39 772
CELLTRION, INC.--.--%36 110
REGENERON PHARMACEUTICALS-12.04%35 529
IQVIA HOLDINGS INC6.93%21 125